Leptomeningeal enhancement (LME) is a novel imaging finding 1 that has been detected on delayed postcontrast fluid-attenuated inversion recovery (FLAIR) images on high-field and ultra-high-field magnetic resonance imaging (MRI). 1-5 LME has been postulated to be pathologically related to the disruption of the blood-meningeal barrier due to leptomeningeal inflammation 1 and potentially ectopic B-cell folliclelike aggregations. In prior imaging studies, LME has been consistently implicated in cortical damage and thinning. [1] [2] [3] [4] [5] There is substantial variability in the reported prevalence of LME, 1-5 but one consistent finding is a greater frequency in progressive forms of multiple sclerosis (MS). [1] [2] [3] There is also evidence that LME is not specific to MS occurring frequently in other inflammatory/infectious neurological disorders as well. 6 In the current issue, two experienced imaging research groups investigated the association of LME and cortical demyelinated lesions using 7T MRI with contradictory results. The two cross-sectional studies were comparable in terms of 7T MRI sequence protocol and overall imaging postprocessing and analysis. MRI protocols included both Magnetization-Prepared 2 Rapid Gradient Echoes (MP2RAGE) and postcontrast FLAIR images for cortical lesions and LME detection, respectively.
Ighani et al. 7 studied a mixed cohort of relapsing (n = 31) and progressive (n = 10) MS cases, 80.5% of whom were found to have LME. No differences in the cortical lesion number/volume were detected when comparing those with and without LME, even when considering cortical lesion subgroups and when hippocampal lesions were analyzed separately. Zurawski et al. 8 enrolled only relapsing MS cases (n = 30), 67% of whom featured LME. In this cohort, LME-positive cases had a fourfold increase in the cortical lesion number, a fivefold increase in thalamic lesions, and a fourfold increase in white matter lesions compared with LME-negative cases.
Several explanations can be hypothesized for these seemingly contradictory findings. It is critical to highlight that the authors aimed to identify and correlate two imaging features for which techniques are suboptimal and for which detection rates remain low. For cortical lesions, even at 7T, only a small proportion of lesions are visible when compared with pathological studies. 9, 10 In addition, little is known in terms of onset and longitudinal evolution of both LME and cortical lesions. There are some other clinical/imaging differences in these two relatively small cohorts (<45 MS cases) that might have resulted in a selection bias. In the Ighani et al. 7 paper, the higher LME detection rate (80.5% LME-positive cases) and the inclusion of different disease phenotypes might have led to some unbalance affecting the statistical power. In the Zurawski et al. 8 paper, relapsing cases with LME (67%) had not only longer disease duration (mean 14 vs. 8 years) but also significantly higher overall lesion burden and brain damage. It is possible that the overall greater lesion burden effectively produced greater power to detect a relation with LME.
Although these two studies provide contradictory evidence of an association of LME with cortical lesions, several important points can still be made. The correlation of LME with cortical and brain volume, as well as cortical thickness, appears more robust than the relation with cortical lesions. This is a finding that has been confirmed in previous studies. [1] [2] [3] [4] [5] Prior reports 1-5 also suggested that LME may be more prevalent in progressive MS, where new lesion formation is more scarce. In this context, the relation of more diffuse cortical/brain measures of damage correlating with LME is quite interesting and should prompt further investigation. Ultimately, it is not yet clear whether LME is an imaging biomarker for ongoing meningeal inflammation as opposed to prior disease activity. We also still do not know if LME relates to diffuse as opposed to compartmentalized meningeal inflammation. The effect on cortical thickness would suggest a role of LME in
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Several key questions regarding LME continue to exist, and multiple issues need to be addressed in studies going forward. Methods for LME detection vary significantly from group to group and may explain the lack of uniformity in the results of LME highlighted in the above-mentioned studies but also in prior publications. Uniform image analysis protocols, similar to what has been implemented for detection of brain volume and T2 lesions, are needed to make results across studies comparable. Topics that still need to be further addressed include identifying the temporal pattern of LME over time, the pathology correlates of LME (expanding initial MRI pathology results), 1 the relation of LME to disability, and the response of LME to disease-modifying therapies. Several of these questions would perhaps be best answered by an adequately powered longitudinal study conducted across several sites with state-of-theart imaging and detailed phenotypic characterization. Better understanding this striking image finding may help explain the tremendous amount of disease heterogeneity that is encountered in clinical practice and may help refine prediction and treatment response.
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